Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials by Jabbour, Elias, Apperley, Jane, Cortes, Jorge, Rea, Delphine, Deininger, Michael, Abruzzese, Elisabetta, Chuah, Charles, DeAngelo, Daniel J., Hochhaus, Andreas, Lipton, Jeffrey H., Mauro, Michael, Nicolini, Franck, Pinilla-Ibarz, Javier, Rosti, Gianantonio, Rousselot, Philippe, Shah, Neil P., Talpaz, Moshe, Vorog, Alexander, Ren, Xiaowei, Kantarjian, Hagop

Get full text

Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis by Shah, Neil P., Kasap, Corynn, Weier, Christopher, Balbas, Minna, Nicoll, John M., Bleickardt, Eric, Nicaise, Claude, Sawyers, Charles L.

Get full text

Infant colitis—it's in the genes by Glocker, Erik-Oliver, MD, Frede, Natalie, Perro, Mario, MSc, Sebire, Neil, Prof, Elawad, Mamoun, MD, Shah, Neil, MD, Grimbacher, Bodo, Prof

Get full text

Dasatinib or High-Dose Imatinib for Chronic-Phase Chronic Myeloid Leukemia Resistant to Imatinib at a Dose of 400 to 600 Milligrams Daily: Two-Year Follow-Up of a Randomized Phase... by KANTARJIAN, Hagop, PASQUINI, Ricardo, SHAH, Neil P, LEVY, Vincent, JOOTAR, Saengsuree, HOLOWIECKI, Jerzy, HAMERSCHLAK, Nelson, HUGHES, Timothy, BLEICKARDT, Eric, DEJARDIN, David, CORTES, Jorge

Get full text

BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib by Leyte-Vidal, Ariel, Garrido Ruiz, Diego, DeFilippis, RosaAnna, Leske, Inga B., Rea, Delphine, Phan, Stacey, Miller, Kaeli B., Hu, Feifei, Mase, Anjeli, Shan, Yibing, Hantschel, Oliver, Jacobson, Matthew P., Shah, Neil P.

Get full text

Making the transition from traditional to robotic-arm assisted TKA: What to expect? A single-surgeon comparative-analysis of the first-40 consecutive cases by Naziri, Qais, Cusson, Barry C, Chaudhri, Moiuz, Shah, Neil V, Sastry, Akhilesh

Get full text

A pilot biomechanical study comparing a novel, intramedullary Nail/Plate construct to standard Dual-Plate fixation of intra-articular C2.3 distal humerus fractures by Shah, Neil V., Hayes, Westley T., Wang, Hanbin, Hordines, John C., Karakostas, Jonathan E., Paxinos, Odysseas, Koehler, Steven M.

Get full text

Complex Genomic Rearrangements Involving ETV6::ABL1 Gene Fusion in an Individual with Myeloid Neoplasm by Qi, Zhongxia, Smith, Catherine, Shah, Neil P., Yu, Jingwei

Get full text

An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L by Wang, Xiuqi, DeFilippis, Rosa Anna, Weldemichael, Tsigereda, Gunaganti, Naresh, Tran, Phuc, Leung, Yuet-Kin, Shah, Neil P, Li, Hong-Yu

Get full text

PPARγ: Welcoming the New Kid on the CML Stem Cell Block by Apsel Winger, Beth, Shah, Neil P.

Get full text

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III study by Wang, Xiaoning, Roy, Amit, Hochhaus, Andreas, Kantarjian, Hagop M, Chen, Tai-Tsang, Shah, Neil P

Get full text

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy by Hochhaus, Andreas, Kantarjian, Hagop M., Baccarani, Michele, Lipton, Jeffrey H., Apperley, Jane F., Druker, Brian J., Facon, Thierry, Goldberg, Stuart L., Cervantes, Francisco, Niederwieser, Dietger, Silver, Richard T., Stone, Richard M., Hughes, Timothy P., Muller, Martin C., Ezzeddine, Rana, Countouriotis, Athena M., Shah, Neil P.

Get full text

Endoscopic ultrasound and the liver: current applications and beyond by Shah, Neil D., Baron, Todd H.

Get full text

A case of checkpoint inhibitor-induced celiac disease by Alsaadi, Dana, Shah, Neil J, Charabaty, Aline, Atkins, Michael B

Get full text

Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency by Shah, Neil P, Skaggs, Brian J, Branford, Susan, Hughes, Timothy P, Nicoll, John M, Paquette, Ronald L, Sawyers, Charles L

Get full text

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia by Shah, Neil P., Nicoll, John M., Nagar, Bhushan, Gorre, Mercedes E., Paquette, Ronald L., Kuriyan, John, Sawyers, Charles L.

Get full text

Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia by Flynn, Kathryn E, Atallah, Ehab, Lin, Li, Shah, Neil P, Silver, Richard T, Larson, Richard A, Panilla-Ibarz, Javier, Thompson, James E, Oehler, Vivian G, Radich, Jerald P, Kota, Vamsi, Mauro, Michael J, Schiffer, Charles A, Cortes, Jorge, Weinfurt, Kevin P

Get full text

Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity by Schiffer, Charles A., Cortes, Jorge E., Hochhaus, Andreas, Saglio, Giuseppe, le Coutre, Philipp, Porkka, Kimmo, Mustjoki, Satu, Mohamed, Hesham, Shah, Neil P.

Get full text

The impact of surgical trainee involvement in total knee arthroplasty: a systematic review of surgical efficacy, patient safety, and outcomes by Marder, Ryan S., Shah, Neil V., Naziri, Qais, Maheshwari, Aditya V.

Get full text

Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase ch... by SHAH, Neil P, KIM, Dong-Wook, LAMBERT, Alexandre, MATLOUB, Yousif, HOCHHAUS, Andreas, KANTARJIAN, Hagop, ROUSSELOT, Philippe, DORLHIAC LLACER, Pedro Enrique, ENRICH, Alicia, VELA-OJEDA, Jorge, SILVER, Richard T, KHOURY, Hanna Jean, MÜLLER, Martin C

Get full text